CRP and Cognitive impairment: This single-center quasi-experimental study demonstrated that 12 weeks of nightly melatonin supplementation (5 mg) significantly improved cognitive performance and reduced HbA1C and CRP levels in patients with type 2 diabetes and mild to moderate cognitive impairment.